We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+15.83%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$7.92B
AUM Growth
+$2.08B
Cap. Flow
+$1.31B
Cap. Flow %
16.61%
Top 10 Hldgs %
41.43%
Holding
197
New
67
Increased
35
Reduced
38
Closed
55

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$372M
2
DG icon
Dollar General
DG
+$308M
3
HCA icon
HCA Healthcare
HCA
+$305M
4
CHTR icon
Charter Communications
CHTR
+$180M
5
CF icon
CF Industries
CF
+$162M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$210M
2
LYB icon
LyondellBasell Industries
LYB
+$202M
3
BA icon
Boeing
BA
+$181M
4
FDX icon
FedEx
FDX
+$151M
5
AIG icon
American International
AIG
+$106M

Sector Composition

Rank Sector Weight
1 Communication Services 21.51%
2 Healthcare 20.57%
3 Energy 18.19%
4 Industrials 10.52%
5 Materials 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOL icon
176
Toll Brothers
TOL
$14.2B
– –
-60,600
Closed -$1.97M
UPBD icon
177
Upbound Group
UPBD
$1.23B
– –
-77,880
Closed -$2.97M
V icon
178
Visa
V
$709B
– –
-541,600
Closed -$25.9M
XNTK icon
179
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.96B
– –
-1,000,000
Closed -$41M
ZTS icon
180
Zoetis
ZTS
$32.9B
– –
-460,020
Closed -$14.3M
SGI
181
Somnigroup International
SGI
$14.2B
– –
-500,000
Closed -$5.5M
JOYY
182
JOYY Inc
JOYY
$3.73B
– –
-148,800
Closed -$6.96M
SPPI
183
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-1,000,000
Closed -$8.38M
CLR
184
DELISTED
CONTINENTAL RESOURCES INC.
CLR
– –
-186,400
Closed -$10M
VIAB
185
DELISTED
Viacom Inc. Class B
VIAB
– –
-219,600
Closed -$18.4M
ESRX
186
DELISTED
Express Scripts Holding Company
ESRX
– –
-350,000
Closed -$21.6M
MON
187
DELISTED
Monsanto Co
MON
– –
-664,200
Closed -$69.3M
CASC
188
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-83,333
Closed -$1.03M
CAA
189
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-19,933
Closed -$788K
GEVA
190
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-170,000
Closed -$10.8M
TRW
191
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
– –
-27,000
Closed -$1.93M
SLXP
192
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-530,000
Closed -$35.4M
AUXL
193
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-275,000
Closed -$5M
VPHM
194
DELISTED
VIROPHARMA INC
VPHM
– –
-2,217,200
Closed -$87M
ONXX
195
CALL
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
– –
-100,000
Closed -$12.5M
WCRX
196
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
– –
-3,000,000
Closed -$68.8M
MDVN
197
DELISTED
MEDIVATION, INC.
MDVN
– –
-500,000
Closed -$15M
4 5 6 7
8

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

PointState Capital's Q4 2013 Portfolio in Review

As of Q4 2013, PointState Capital held 197 positions worth $7.92B, up 36% from $5.84B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

PointState Capital deployed $1.31B of net new capital in Q4 2013, opening 67 new positions and adding to 35 existing holdings. Its largest new stake was Teva Pharmaceuticals: 9,445,400 shares worth $379M.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $210M trimmed.

  • PointState Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 9,445,400 shares worth $379M.
  • PointState Capital added most to Dollar General in Q4 2013, an estimated $308M increase.
  • PointState Capital's biggest Q4 2013 reduction was Allergan Inc, cutting an estimated $210M.
  • PointState Capital fully exited LyondellBasell Industries in Q4 2013, selling an estimated $202M.
  • PointState Capital's ten largest holdings make up 41% of its $7.92B portfolio in Q4 2013.
  • PointState Capital opened 67 new positions and closed 55 in Q4 2013.
  • PointState Capital's portfolio value rose 36% quarter-over-quarter to $7.92B.

Based on PointState Capital's 13F filing for Q4 2013, filed 14 Feb 2014.